228 related articles for article (PubMed ID: 29209144)
1. Targeting the long noncoding RNA MALAT1 blocks the pro-angiogenic effects of osteosarcoma and suppresses tumour growth.
Zhang ZC; Tang C; Dong Y; Zhang J; Yuan T; Tao SC; Li XL
Int J Biol Sci; 2017; 13(11):1398-1408. PubMed ID: 29209144
[TBL] [Abstract][Full Text] [Related]
2. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway.
Dong Y; Liang G; Yuan B; Yang C; Gao R; Zhou X
Tumour Biol; 2015 Mar; 36(3):1477-86. PubMed ID: 25431257
[TBL] [Abstract][Full Text] [Related]
3. Expression profiling of long noncoding RNAs associated with vasculogenic mimicry in osteosarcoma.
Ren K; Ni Y; Li X; Wang C; Chang Q; Li Y; Gao Z; Wu S; Shi X; Song J; Yao N; Zhou J
J Cell Biochem; 2019 Aug; 120(8):12473-12488. PubMed ID: 30825232
[TBL] [Abstract][Full Text] [Related]
4. The long noncoding RNA MALAT1 promotes tumor-driven angiogenesis by up-regulating pro-angiogenic gene expression.
Tee AE; Liu B; Song R; Li J; Pasquier E; Cheung BB; Jiang C; Marshall GM; Haber M; Norris MD; Fletcher JI; Dinger ME; Liu T
Oncotarget; 2016 Feb; 7(8):8663-75. PubMed ID: 26848616
[TBL] [Abstract][Full Text] [Related]
5. FOXO1-MALAT1-miR-26a-5p Feedback Loop Mediates Proliferation and Migration in Osteosarcoma Cells.
Wang J; Sun G
Oncol Res; 2017 Nov; 25(9):1517-1527. PubMed ID: 28160461
[TBL] [Abstract][Full Text] [Related]
6. MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2.
Huo Y; Li Q; Wang X; Jiao X; Zheng J; Li Z; Pan X
Oncotarget; 2017 Jul; 8(29):46993-47006. PubMed ID: 28388584
[TBL] [Abstract][Full Text] [Related]
7. Analysis of hypoxia-induced noncoding RNAs reveals metastasis-associated lung adenocarcinoma transcript 1 as an important regulator of vascular smooth muscle cell proliferation.
Brock M; Schuoler C; Leuenberger C; Bühlmann C; Haider TJ; Vogel J; Ulrich S; Gassmann M; Kohler M; Huber LC
Exp Biol Med (Maywood); 2017 Mar; 242(5):487-496. PubMed ID: 28056547
[TBL] [Abstract][Full Text] [Related]
8. Targeting LncRNA-MALAT1 suppresses the progression of osteosarcoma by altering the expression and localization of β-catenin.
Zhang ZC; Tang C; Dong Y; Zhang J; Yuan T; Li XL
J Cancer; 2018; 9(1):71-80. PubMed ID: 29290771
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MALAT1-related signaling pathways in osteosarcoma.
Farzaneh M; Najafi S; Anbiyaee O; Azizidoost S; Khoshnam SE
Clin Transl Oncol; 2023 Jan; 25(1):21-32. PubMed ID: 35790599
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA MALAT1 as a potential therapeutic target in osteosarcoma.
Cai X; Liu Y; Yang W; Xia Y; Yang C; Yang S; Liu X
J Orthop Res; 2016 Jun; 34(6):932-41. PubMed ID: 26575981
[TBL] [Abstract][Full Text] [Related]
11. MALAT1 promotes osteosarcoma development by targeting TGFA via MIR376A.
Luo W; He H; Xiao W; Liu Q; Deng Z; Lu Y; Wang Q; Zheng Q; Li Y
Oncotarget; 2016 Aug; 7(34):54733-54743. PubMed ID: 27458156
[TBL] [Abstract][Full Text] [Related]
12. Antisense lncRNA FOXF1-AS1 Promotes Migration and Invasion of Osteosarcoma Cells Through the FOXF1/MMP-2/-9 Pathway.
Kun-Peng Z; Chun-Lin Z; Xiao-Long M
Int J Biol Sci; 2017; 13(9):1180-1191. PubMed ID: 29104509
[TBL] [Abstract][Full Text] [Related]
13. Apurinic/apyrimidinic endonuclease 1 induced upregulation of fibroblast growth factor 2 and its receptor 3 induces angiogenesis in human osteosarcoma cells.
Ren T; Qing Y; Dai N; Li M; Qian C; Yang Y; Cheng Y; Li Z; Zhang S; Zhong Z; Wang D
Cancer Sci; 2014 Feb; 105(2):186-94. PubMed ID: 24329908
[TBL] [Abstract][Full Text] [Related]
14. [Effect of silencing HIF-1alpha by RNA interference on expression of vascular endothelial growth factor in osteosarcoma cell line SaOS-2 under hypoxia].
Wu Q; Yang SH; Wang RY; Ye SN; Xia T; Ma DZ
Ai Zheng; 2005 May; 24(5):531-5. PubMed ID: 15890092
[TBL] [Abstract][Full Text] [Related]
15. Role of Nrf2 in MALAT1/ HIF-1α loop on the regulation of angiogenesis in diabetic foot ulcer.
Jayasuriya R; Dhamodharan U; Karan AN; Anandharaj A; Rajesh K; Ramkumar KM
Free Radic Biol Med; 2020 Aug; 156():168-175. PubMed ID: 32473205
[TBL] [Abstract][Full Text] [Related]
16. 17β‑Estradiol treatment drives Sp1 to upregulate MALAT‑1 expression and epigenetically affects physiological processes in U2OS cells.
Hu Q; Li S; Chen C; Zhu M; Chen Y; Zhao Z
Mol Med Rep; 2017 Mar; 15(3):1335-1342. PubMed ID: 28098894
[TBL] [Abstract][Full Text] [Related]
17. MALAT1 promotes angiogenesis of breast cancer.
Huang XJ; Xia Y; He GF; Zheng LL; Cai YP; Yin Y; Wu Q
Oncol Rep; 2018 Nov; 40(5):2683-2689. PubMed ID: 30226550
[TBL] [Abstract][Full Text] [Related]
18. A novel long non-coding RNA, hypoxia-inducible factor-2α promoter upstream transcript, functions as an inhibitor of osteosarcoma stem cells in vitro.
Wang Y; Yao J; Meng H; Yu Z; Wang Z; Yuan X; Chen H; Wang A
Mol Med Rep; 2015 Apr; 11(4):2534-40. PubMed ID: 25434862
[TBL] [Abstract][Full Text] [Related]
19. CCL21 Induces mTOR-dependent MALAT1 Expression, Leading to Cell Migration in Cutaneous T-Cell Lymphoma.
Hong CH; Lin SH; Lee CH
In Vivo; 2019; 33(3):793-800. PubMed ID: 31028199
[TBL] [Abstract][Full Text] [Related]
20. A long non-coding RNA contributes to doxorubicin resistance of osteosarcoma.
Zhang CL; Zhu KP; Shen GQ; Zhu ZS
Tumour Biol; 2016 Feb; 37(2):2737-48. PubMed ID: 26408180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
